Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)

Q: What does CUSIP 471871202 represent in this 13F holders report?

CUSIP 471871202 is the security identifier for JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share in Q3 2024?

77 institutional investors reported JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share for Q3 2024. Use the holders table for investor-level position and value details.

CUSIP: 471871202

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Voting Common Stock, par value $0.0001 per share
Total 13F shares: 14,676,954
Total 13F value: $274,620,688
Share change: +11,183
Put/Call ratio: 41%
SEC-reported price per share: $18.81
Number of holders: 77
Value change: -$5,485,865
Number of buys: 42
Number of sells: 31
Shares outstanding: 33,973,202

Security key

471871202

Report period

Q3 2024

Institutions

Top holders

JSPR full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Jasper Therapeutics, Inc. SEC filings Jasper Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 471871202

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of JSPR - Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Velan Capital Investment ...

Disclosed value leader

Velan Capital Investment ...

Comparable rows

0/15

Latest evidence

30 Jun 2024

13F 3/4/5 Highest disclosed value: $32,547,896 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Velan Capital Investment Management LP has the largest disclosed position value at $32.55M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Velan Capital Investment Management LP's linked filing trail.

Disclosed position value Top 5

Velan Capital Investment Manageme... $32.55M

Carlyle Group Inc. $24.2M

Qiming U.S. Healthcare Fund II, L.P. $5.53M

ROCHE HOLDING LTD $2.95M

Amplitude Healthcare Holdings LLC $1.49M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Velan Capital Investment Management LP	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$32,547,896 1,471,904 shares	—	30 Jun 2024
Carlyle Group Inc.	13F 3/4/5 Company · Former 10% Owner 13F 3/4/5	— denominator unverified	$24,202,490 1,066,189 shares	—	30 Jun 2024
Qiming U.S. Healthcare Fund II, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$5,525,844 8,519,648 shares	—	27 Jan 2023
ROCHE HOLDING LTD	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$2,950,874 4,549,606 shares	—	25 Jan 2023
Amplitude Healthcare Holdings LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$1,491,780 2,300,000 shares	—	24 Sep 2021
Abingworth LLP	3/4/5 10%+ Owner 3/4/5	— denominator unverified	— 78,045 shares	—	21 Mar 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

14,676,954

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend